CRP and COVID-19: Higher troponins, CPK-MB and indicators of inflammation, including D-dimer, CRP, ferritin and LDH,are highly recorded and can be associated with poor clinical outcomes [7, 8].Other risk factors that may alter the development of ACS in the case of COVID-19 are age, sex and comorbidities, including diabetes andhypertension [9, 10].